InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Iannone Robert, Directeur Médical. Officer active across 1 companies, notably Jazz Pharmaceuticals plc. Cumulatively, 4 reports have been published. The latest transaction was disclosed on 6 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€180,7791,295 shares@ €139.5980.0013% mcap34.0% of flow
Ordinary Shares
SEC:0001765581-22-000061:0·
011,374 shares0
Ordinary Shares
SEC:0001765581-22-000019:0·
€175,4081,206 shares@ €145.44620.0012% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-21-000063·
€175,4081,206 shares@ €145.44620.0012% mcap33.0% of flow
Ordinary Shares
SEC:0001765581-21-000063:0·
4 of 4 declarations
About Iannone Robert
Robert Iannone is the Chief Medical Officer and EVP, Global Head of R&D at Jazz Pharmaceuticals plc. He oversees the company's research and development initiatives, ensuring that projects align with strategic goals. His expertise in medical research and drug development is essential for innovation and improvement of treatments offered by Jazz Pharmaceuticals. He plays a key role in the scientific direction of the company.
